Image

The Effect of Pharyngeal Electrical Stimulation on Peripheral Biomechanical Aspects of Deglutition

The Effect of Pharyngeal Electrical Stimulation on Peripheral Biomechanical Aspects of Deglutition

Recruiting
18-80 years
All
Phase N/A

Powered by AI

Overview

The goal of this clinical trial is to clarify which biomechanical aspects of swallowing are altered by Pharyngeal Electrical Stimulation (PES) in stroke patients and healthy volunteers.

The peripheral effect of PES intervention on the biomechanics of swallowing will be evaluated with High Resolution Manometry Impedance (HRMI).

Description

HRMI combines the evaluation of bolus flow patterns (impedance) and pressure (manometry) generated during swallowing.

20 healthy volunteers will participate, of which 10 will receive PES stimulation and 10 will receive Sham treatment.

60 patients with dysphagia after acute first stroke will be included. 20 will receive PES stimulation twice, 20 will receive PES stimulation and afterwards Sham and 20 will receive Sham twice.

Eligibility

Inclusion Criteria volunteers:

Healthy volunteers can participate in this study if they:

  • Are aged between 18 and 80 years old
  • Have no (history of) chronic disease/medication altering the gastrointestinal (GI) motility
  • Have no (history of) gastric or gastrointestinal surgery (except appendectomy and cholecystectomy)
  • Have no (history of) gastrointestinal disease or chronic GI symptoms (heartburn, indigestion/dyspepsia, bloating and constipation)
  • Have FOIS score 7 or BEDQ score <10 at baseline
  • Provide witnessed written informed consent prior to any study procedure And if they do not meet any of the exclusion criteria listed below.

Exclusion Criteria volunteers:

Healthy volunteers will be excluded if they:

  • Are aged <18 years or >80 years
  • Have (any history of) a chronic disease/medication altering the GI motility
  • Have (any history of) gastric or gastrointestinal surgery (except appendectomy and cholecystectomy)
  • Have (any history of) gastrointestinal disease or chronic GI symptoms (heartburn, indigestion/dyspepsia, bloating and constipation)
  • Have a FOIS score <7 or a BEDQ score ≥ 10 at baseline
  • Fail to provide witnessed written informed consent prior to any study procedure

Inclusion Criteria patients:

Dysphagic stroke patients are eligible for study participation if they:

  • Are admitted to the hospital because of first ever acute stroke (acute means assessment within one month post stroke onset)
    • Hemorrhagic and ischemic stroke
    • Supratentorial and infratentorial stroke
  • Are aged between 18 and 80 years old
  • Are medically stable, alert or arousable
  • Have clinical (oropharyngeal) dysphagia well identified using the FOIS/DSRS/ BEDQ/PAS at baseline. In line with earlier studies, we use the following criteria: a DSRS score of 6 or higher; or a FOIS-score equal to or lower than 5; or a BEDQ score of 10 or higher or (when no oral food intake is possible and DSRS score is 12/FOIS score is 1) a PAS-score of 4 or higher
  • Give (or have a witness to give) voluntary written informed consent And if they do not meet any of the exclusion criteria listed below.

Exclusion Criteria patients:

Patients will be excluded from study participation if:

  • They are aged <18 years or >80 years
  • They have an additional condition (e.g. advanced dementia) or diagnosis of a progressive neurological disorder or neuromuscular disorder that may explain dysphagia
  • They have normal swallowing at baseline assessed with FOIS/DSRS/BEDQ/PAS
  • They participate in any other study potentially influencing the outcome of PES, both medicinal or medical device product related and for which the patient signed a consent form for his/her study participation
  • They receive or have received within one month prior to the intended PES treatment any form of non-invasive brain stimulation or percutaneous electrical stimulation therapy to treat dysphagia. (This is no issue, since this type of treatment is not performed at University Hospitals Leuven (UZ Leuven).
  • It is not possible to pass a standard nasogastric tube, for example, nasal, oral or pharyngeal anatomical abnormalities that preclude passage of a feeding tube, oral intubation, history of oesophageal perforation, stricture or pouch
  • They have a cardiac or respiratory condition that might render the insertion of a catheter into the throat unsafe (Atrial fibrillation does not render the insertion of a catheter unsafe)
  • They have a permanently implanted electrical device
  • They are pregnant
  • They present with an oropharyngeal infection. This should be treated and resolved before the PES catheter is inserted
  • They require a magnetic resonance imaging (MRI) scan during PES treatment. Insertion of the PES catheter should either be delayed until such time as the MRI has been completed, or the PES catheter should be removed and discarded and a new catheter inserted after the MRI is completed

Study details
    Dysphagia Following Cerebrovascular Accident
    Dysphagia

NCT05666141

Universitaire Ziekenhuizen KU Leuven

27 January 2024

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.